Featured Articles
-
Operationalizing Disclosure Intelligence For Compliance At Scale
1/19/2024
Learn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.
-
Overcoming Burden In Patient Engagement And Recruitment
12/18/2023
Learn how to gauge success by addressing the challenges that patient engagement and recruitment places on sites, as well as patients.
-
Drug Review Profiles: A Deep Dive Into New Drug Approvals
12/18/2023
Explore the dynamics behind interesting and sometimes precedent-setting new drug approvals and uncover how the regulatory process works in practice.
-
Regional Comparisons Of Pharmaceutical Regulations
12/18/2023
Uncover how performance and regulatory expectations differ for regulatory agencies in various markets, influenced by regional drug review trends, approval decisions, and regulatory guidance.
-
Phase 1-3: Clinical Trials Overview
11/20/2023
Various macroeconomic pressures faced by the biopharma industry led to a crunch in funding. In addition, economic and political factors contributed to a decline in clinical trials.
-
Patient Retention: Quality Of Life Is Key
11/20/2023
Sponsors working to address the dropout rate for Phase 3 clinical trials should review this insight on how to be more mindful of the patient's quality of life and how that can boost retention.
-
Recruitment: Meeting Patients Where They Are
11/20/2023
One of the biggest challenges in recruiting patients for a clinical study is creating awareness among potential participants. Learn why sponsors must find better ways to get the word out.
-
The Annual Clinical Trials Roundup
11/20/2023
Delve into in-depth analyses of key diseases, players, and geographies influencing the pharmaceutical industry through an overview of Phase 1–3 clinical trials initiated in 2022 across all therapeutic areas.
-
3 Ways Clinical Trial Diversity Can Put Sponsors On Top
11/20/2023
Get an overview of sponsors' ongoing challenges regarding diversity in clinical trials and the innovative ways they are striving to overcome them.
-
A 26-Year Journey To Reach A Complex Rare Disease Diagnosis
10/19/2023
Haley Quinn, Director of Product Success for Citeline Connect, shares her own medical journey and how it both impassions her and impacts her work on a day-to-day basis.